Overview
- 244 inspections across 203 sites are on record.
- 190 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-02-11.
At a glance
Inspections
244
Sites
203
Observations
190
Career since
Feb 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | 11 Feb 2026 | Biologics | |
| Jeffrey S. Dover, MD | 24 Sep 2025 | Human Drugs | |
| Pasi A. Janne, M.D., Ph.D. | 15 Sep 2025 | Human Drugs | |
| Katarzyna Jarus-Dziedzic MD, PhD | 31 Jul 2025 | Tobacco Products | |
| Piotr Sobieraj M.D. | 25 Jul 2025 | Tobacco Products |
Sites inspected
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCAndover, United States1 insp.
Jeffrey S. Dover, MDChestnut Hill, United States1 insp.
Pasi A. Janne, M.D., Ph.D.Boston, United States1 insp.
Katarzyna Jarus-Dziedzic MD, PhDWarsaw, Poland1 insp.
Piotr Sobieraj M.D.Warsaw, Poland1 insp.
Co-investigators
Investigators who share inspections with this person.
Meredith L Miller10 shared
Douglas Fiorentino6 shared
Asia D Clark5 shared
Jose A Torres5 shared
Alicia A Dalley4 shared
Kent A Conforti4 shared
John L Zaccone4 shared
Michael P Anthony3 shared
Anthony W Thomas3 shared
Erin M Mcdowell2 shared
Full investigator report
Get the verbatim findings behind Matthew C Watson's 190 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site